Bovie Medical Co. (NYSE:BVX) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 117,344 shares, an increase of 168.2% from the December 31st total of 43,754 shares, MarketBeat reports. Based on an average daily volume of 62,508 shares, the days-to-cover ratio is presently 1.9 days. Currently, 0.5% of the company’s stock are short sold.

Separately, Zacks Investment Research downgraded Bovie Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 2nd.

In related news, insider John J. Mccarthy III acquired 25,000 shares of the stock in a transaction dated Tuesday, December 22nd. The stock was purchased at an average cost of $1.98 per share, with a total value of $49,500.00. Following the completion of the purchase, the insider now directly owns 25,000 shares in the company, valued at approximately $49,500. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Moshe Citronowicz acquired 20,000 shares of the stock in a transaction dated Monday, December 21st. The stock was bought at an average cost of $1.84 per share, with a total value of $36,800.00. Following the completion of the purchase, the vice president now owns 426,504 shares of the company’s stock, valued at $784,767.36. The disclosure for this purchase can be found here.

Shares of Bovie Medical (NYSE:BVX) opened at 2.20 on Friday. The company’s 50 day moving average price is $2.11 and its 200-day moving average price is $2.11. The stock has a market capitalization of $59.51 million and a P/E ratio of 20.00. Bovie Medical has a 12 month low of $1.72 and a 12 month high of $3.79.

Bovie Medical (NYSE:BVX) last announced its quarterly earnings results on Wednesday, November 4th. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.06). The business had revenue of $7.80 million for the quarter, compared to analysts’ expectations of $7.40 million. Equities analysts predict that Bovie Medical will post ($0.29) earnings per share for the current year.

Bovie Medical Corporation (NYSE:BVX) is an energy-based medical device company. The Company is engaged in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor’s offices, surgery centers and hospitals around the world. It is also engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers. It also develops J-Plasma, a plasma-based surgical product. The Company operates through three segments: Core, OEM and J-Plasma. The Company’s medical devices are marketed through its own brands, including Bovie, Aaron, IDS and ICON) and on a private label basis to distributors throughout the world. The Company offers its products in three categories: electrosurgery, cauteries and other products. Its electrosurgery products include desiccators, generators, electrodes, electrosurgical pencils and various ancillary disposable products.

12 Month Chart for NYSE:BVX

Receive News & Ratings for Bovie Medical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical Co. and related companies with MarketBeat.com's FREE daily email newsletter.